← Back to Search

GogyUp for Health Literacy

N/A
Waitlist Available
Led By Ned Zimmerman-Bence
Research Sponsored by GogyUp Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 - 6 months
Awards & highlights

Study Summary

This trial will study if using an app with print materials can help people with limited reading skills better understand diabetes self-management education and improve their diabetes management.

Who is the study for?
This trial is for adults aged 18-85 with Type 2 Diabetes who have visited a clinic in the last year and can understand English. They must be able to give consent and not be pregnant or involved in another treatment study.Check my eligibility
What is being tested?
The GogyUp Reader app, an assistive reading technology, is being tested to see if it helps diabetic patients better understand health materials for self-management. The study compares using the app with standard print materials against using print materials alone.See study design
What are the potential side effects?
Since this trial involves an educational technology rather than a medical intervention, traditional physical side effects are not expected. However, users may experience frustration or difficulty if they struggle with using the app.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 - 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 - 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Health Literacy Questionnaire Subscale 2: having sufficient information to manage my health
Health Literacy Questionnaire subscale 9: Understanding health information well enough to know what to do
Secondary outcome measures
Perceived Diabetes Self-Management Scale score
Other outcome measures
Change from Baseline Value of A1c (HbA1c)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GogyUpExperimental Treatment1 Intervention
Participants in the GogyUp arm will have the GogyUp Reader app preloaded on a cellular-enabled tablet with the same patient education documents as the Control arm. Patients will be able to use on-demand / in-the-moment assistive-reading technologies to understand any word or phrase: Speech-to-Text Word-by-Word Translation Alternative Formatting Simplified and Contextualized Definitions No-Fail Comprehension Questions Personalized Training in Phonemic Awareness
Group II: ControlActive Control1 Intervention
Participants in the Standard Care arm will receive the standard after-visit patient education documents the clinics current provide for type 2 diabetes education and self-management.

Find a Location

Who is running the clinical trial?

GogyUp IncLead Sponsor
University of MinnesotaOTHER
1,379 Previous Clinical Trials
1,588,332 Total Patients Enrolled
Ned Zimmerman-BencePrincipal InvestigatorGogyUp Inc

Media Library

GogyUp Reader Clinical Trial Eligibility Overview. Trial Name: NCT05337306 — N/A
Health Literacy Research Study Groups: GogyUp, Control
Health Literacy Clinical Trial 2023: GogyUp Reader Highlights & Side Effects. Trial Name: NCT05337306 — N/A
GogyUp Reader 2023 Treatment Timeline for Medical Study. Trial Name: NCT05337306 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this research restricted to those aged 25 and above?

"Adults with ages ranging from 18 to 85 are qualified to participate in this trial. Those under the age of 18 can find 216 trials suited for them, while those above 65 have 1,129 studies ready for enrollment."

Answered by AI

Are there vacancies for enrollment in this research endeavor?

"According to the clinicaltrials.gov platform, this medical investigation is actively recruiting suitable applicants. The trial was first posted on April 26th and last updated on May 20th of 2023."

Answered by AI

What is the current enrollment cap for this scientific trial?

"Affirmative. Clinicaltrials.gov data indicates that this research project, first published on April 26th 2023, is actively recruiting people to participate in the study. They are searching for 160 participants from 1 medical centre."

Answered by AI

Is it possible to partake in this clinical examination?

"This clinical trial requires 160 participants aged 18-85 who are able to read and write. Moreover, they must provide a signed consent form before enrolling in the study, have recently seen a healthcare professional (April 2020 - February 2021) for type II diabetes mellitus diagnosis, receive patient education materials from their care team, and be comfortable providing consent in English."

Answered by AI

Who else is applying?

What state do they live in?
Minnesota
What site did they apply to?
MHealth Fairview system
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I've just had a spike in my A1c so I need some help to get back on track.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Improving Diabetic Patient Health Through Assistive-Reading Technology
2023. "Improving Diabetic Patient Health Through Assistive-Reading Technology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05337306.
All > Diabetes Type 2
~12 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top